A-Z Index
Image Cart
              

 Information For:

Manufacturers

Regulator

Healthcare

Consumers

Members


Revision Bulletin

Midazolam

Posting Date: 30 October 2009
Official Date: 1 December 2009
Expert Committee: Monograph Development—Pulmonary and Steroids


In accordance with the Rules and Procedures of the 2005-2010 Council of Experts, the Monograph Development-Pulmonary and Steroids Expert Committee has revised the Midazolam monograph by increasing the limit for the desfluoromidazolam impurity in the Chromatographic purity procedure from NMT 0.1% to NMT 0.2%, based on data provided by an FDA-approved sponsor.

This Midazolam Revision Bulletin supersedes the monograph in USP 32–NF 27 Second Supplement and will be incorporated into USP 33–NF 28 First Supplement.

Should you have any questions, please contact Mary Waddell (301-816-8124 or ).

Download the Midazolam Revision Bulletin  (116KB)

What's New

Changes to the Dissolution Performance Verification Test (11/20/09)

PF 35(6) Errata (10/30/09)

New official Text for October: 15 Revisions Bulletins (10/30/09)

Pending Standards for the month of October (10/30/09)

PF 35(6), November-December 2009: Highlights and Stimuli Articles (10/23/09)

Admission Criteria and Safety Classification for Dietary Supplements Guideline (10/22/09)

Elemental Impurities Hot Topics information updated (10/13/09)

General Chapter <1151> Pharmaceutical Dosage Forms (10/06/09)

Heparin Hot Topics information updated (10/02/09)

PF Redesign

Related Resources